7 result(s) for 'Multiplex Staining'
1 - 7 of 7 results for 'Multiplex Staining'
Sort by
Show
Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.
The content of this webinar will encompass detailed technical descriptions of novel and state of the art methods to decalcify tissue samples that will be embedded in paraffin or for frozen sectioning for molecular and nucleic acid analysis for basic research...
In recent years, digital pathology has gone from an intriguing idea to an integral part of how academic and commercial labs operate. Join Leica Biosystems and Procia Digital Pathology as they discuss why institutions are going digital today and how they...
Following a PhD and postdoc in the field of developmental neurobiology, I joined the experimental histopathology team at the Crick in 2017. Within the science technology platform, I primarily lead on the development and application of advanced staining techniques including immunohistochemistry, immunofluorescence, multiplexed staining, and RNAscope.
Dean joined Leica Biosystems in 2016 and is a senior scientist in the R&D team in Melbourne, working on advanced staining projects. He graduated from Monash University where he pursued a PhD, with the department of Immunology and Pathology. During this time, he investigated the role of T cell lineages in mediating inflammatory retinal disorders. He assessed cellular interactions using fluorescent multiplex IHC with confocal microscopy imaging of retinal wholemounts.
Charlotte Gray is an Applications Consultant at Leica Biosystems in the UK, specializing in advanced staining with a particular interest in life science applications. Charlotte has a decade of experience after graduating from the University of Nottingham with a BSc (Hons) Medical Science degree. She started her career as an HCPC registered Biomedical Scientist in the NHS working in Histology and was the lead for her trust’s involvement in the 100,000 Genomes Project. Charlotte then worked at the University of Birmingham as Tissue Services Manager and was responsible for managing a research Histology lab, implementing multiplex IHC/ISH, and contributing to digital analysis. During her time at the university, she completed her MSc in Genomic Medicine degree. Charlotte has interes...
Robyn Broad completed her undergraduate degree in Biochemistry at the University of Manchester, UK in 2014. During her undergraduate degree, she had the opportunity of undertaking a placement year, which she completed at MedImmune, Cambridge UK. During her time at MedImmune, Robyn worked in both the phage display team and histology group, producing, and identifying IHC compatible antibodies for targets where commercial antibodies were not currently available. Following completion of her undergraduate degree, Robyn received her MSc in Cancer Research and Molecular Biomedicine again from the University of Manchester and received her PhD from the School of Medicine at the University of Leeds in 2019, where she investigated the role of cancer-associated fibroblasts on chemoresistan...